AZN Short Volume
AstraZeneca PLC (AZN) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $131.16B, listed on NYSE, employing roughly 96,100 people, carrying a beta of 0.23 to the broader market. AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. Led by Pascal Claude Roland Soriot, public since 1993-05-12.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-07-24
- Short Volume
- 320.5K
- Total Volume
- 768.3K
- Short %
- 41.72%
- 30-Day Avg Short %
- 40.80%
Showing 30 days of FINRA short volume data for AstraZeneca PLC.
Learn how short volume is reported and how to read the data →
Frequently asked AZN short volume questions
- What is the daily AZN short volume?
- As of Jul 24, 2026, AstraZeneca PLC (AZN) short volume is 320.5K shares against 768.3K total reported volume, or 41.72% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is AZN short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does AZN short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.